nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—melanoma—kidney cancer	0.146	0.297	CtDrD
Dactinomycin—muscle cancer—kidney cancer	0.127	0.257	CtDrD
Dactinomycin—testicular cancer—kidney cancer	0.119	0.241	CtDrD
Dactinomycin—ABCB1—kidney cancer	0.103	1	CbGaD
Dactinomycin—sarcoma—kidney cancer	0.101	0.205	CtDrD
Dactinomycin—ABCC6—Vinblastine—kidney cancer	0.06	0.194	CbGbCtD
Dactinomycin—ABCC6—Doxorubicin—kidney cancer	0.0369	0.119	CbGbCtD
Dactinomycin—ABCG2—Pazopanib—kidney cancer	0.0207	0.0669	CbGbCtD
Dactinomycin—ABCC1—Paclitaxel—kidney cancer	0.0202	0.0653	CbGbCtD
Dactinomycin—ABCC1—Vinblastine—kidney cancer	0.0177	0.0573	CbGbCtD
Dactinomycin—ABCC1—Vincristine—kidney cancer	0.0174	0.0563	CbGbCtD
Dactinomycin—ABCG2—Erlotinib—kidney cancer	0.0148	0.0478	CbGbCtD
Dactinomycin—ABCB1—Temsirolimus—kidney cancer	0.0142	0.046	CbGbCtD
Dactinomycin—ABCG2—Paclitaxel—kidney cancer	0.0135	0.0437	CbGbCtD
Dactinomycin—ABCG2—Sorafenib—kidney cancer	0.012	0.0388	CbGbCtD
Dactinomycin—ABCG2—Vincristine—kidney cancer	0.0116	0.0377	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—kidney cancer	0.0109	0.0352	CbGbCtD
Dactinomycin—ABCG2—Sunitinib—kidney cancer	0.00972	0.0315	CbGbCtD
Dactinomycin—ABCB1—Pazopanib—kidney cancer	0.00746	0.0241	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—kidney cancer	0.00728	0.0236	CbGbCtD
Dactinomycin—ABCB1—Gemcitabine—kidney cancer	0.00539	0.0175	CbGbCtD
Dactinomycin—ABCB1—Erlotinib—kidney cancer	0.00532	0.0172	CbGbCtD
Dactinomycin—ABCB1—Paclitaxel—kidney cancer	0.00487	0.0158	CbGbCtD
Dactinomycin—ABCB1—Sorafenib—kidney cancer	0.00433	0.014	CbGbCtD
Dactinomycin—ABCB1—Vinblastine—kidney cancer	0.00427	0.0138	CbGbCtD
Dactinomycin—ABCB1—Vincristine—kidney cancer	0.0042	0.0136	CbGbCtD
Dactinomycin—ABCB1—Sunitinib—kidney cancer	0.0035	0.0113	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—kidney cancer	0.00262	0.0085	CbGbCtD
Dactinomycin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00149	1	CbGdCrCtD
Dactinomycin—Leukopenia—Sunitinib—kidney cancer	0.000105	0.0012	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000104	0.0012	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—kidney cancer	0.000104	0.0012	CcSEcCtD
Dactinomycin—Asthenia—Pazopanib—kidney cancer	0.000104	0.00119	CcSEcCtD
Dactinomycin—Myalgia—Sorafenib—kidney cancer	0.000103	0.00119	CcSEcCtD
Dactinomycin—Erythema multiforme—Gemcitabine—kidney cancer	0.000102	0.00117	CcSEcCtD
Dactinomycin—Pneumonia—Paclitaxel—kidney cancer	0.000101	0.00116	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—kidney cancer	0.0001	0.00116	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.0001	0.00116	CcSEcCtD
Dactinomycin—Alopecia—Vincristine—kidney cancer	0.0001	0.00116	CcSEcCtD
Dactinomycin—Decreased appetite—Vinblastine—kidney cancer	9.96e-05	0.00115	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	9.95e-05	0.00115	CcSEcCtD
Dactinomycin—Myalgia—Sunitinib—kidney cancer	9.94e-05	0.00115	CcSEcCtD
Dactinomycin—Decreased appetite—Everolimus—kidney cancer	9.92e-05	0.00114	CcSEcCtD
Dactinomycin—Diarrhoea—Pazopanib—kidney cancer	9.89e-05	0.00114	CcSEcCtD
Dactinomycin—Liver function test abnormal—Capecitabine—kidney cancer	9.87e-05	0.00114	CcSEcCtD
Dactinomycin—Infection—Sorafenib—kidney cancer	9.84e-05	0.00113	CcSEcCtD
Dactinomycin—Fatigue—Everolimus—kidney cancer	9.84e-05	0.00113	CcSEcCtD
Dactinomycin—Pain—Vinblastine—kidney cancer	9.8e-05	0.00113	CcSEcCtD
Dactinomycin—Stomatitis—Paclitaxel—kidney cancer	9.79e-05	0.00113	CcSEcCtD
Dactinomycin—Pain—Everolimus—kidney cancer	9.76e-05	0.00112	CcSEcCtD
Dactinomycin—Vomiting—Temsirolimus—kidney cancer	9.75e-05	0.00112	CcSEcCtD
Dactinomycin—Thrombocytopenia—Sorafenib—kidney cancer	9.7e-05	0.00112	CcSEcCtD
Dactinomycin—Rash—Temsirolimus—kidney cancer	9.67e-05	0.00111	CcSEcCtD
Dactinomycin—Chills—Gemcitabine—kidney cancer	9.66e-05	0.00111	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Capecitabine—kidney cancer	9.63e-05	0.00111	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Capecitabine—kidney cancer	9.63e-05	0.00111	CcSEcCtD
Dactinomycin—Decreased appetite—Erlotinib—kidney cancer	9.57e-05	0.0011	CcSEcCtD
Dactinomycin—Oedema—Sunitinib—kidney cancer	9.53e-05	0.0011	CcSEcCtD
Dactinomycin—Alopecia—Gemcitabine—kidney cancer	9.51e-05	0.0011	CcSEcCtD
Dactinomycin—Fatigue—Erlotinib—kidney cancer	9.49e-05	0.00109	CcSEcCtD
Dactinomycin—Infection—Sunitinib—kidney cancer	9.47e-05	0.00109	CcSEcCtD
Dactinomycin—Anorexia—Sorafenib—kidney cancer	9.44e-05	0.00109	CcSEcCtD
Dactinomycin—Feeling abnormal—Vinblastine—kidney cancer	9.44e-05	0.00109	CcSEcCtD
Dactinomycin—Pain—Erlotinib—kidney cancer	9.42e-05	0.00108	CcSEcCtD
Dactinomycin—Feeling abnormal—Everolimus—kidney cancer	9.4e-05	0.00108	CcSEcCtD
Dactinomycin—Erythema—Gemcitabine—kidney cancer	9.37e-05	0.00108	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vinblastine—kidney cancer	9.37e-05	0.00108	CcSEcCtD
Dactinomycin—Thrombocytopenia—Sunitinib—kidney cancer	9.33e-05	0.00108	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Everolimus—kidney cancer	9.33e-05	0.00108	CcSEcCtD
Dactinomycin—Dysphagia—Capecitabine—kidney cancer	9.24e-05	0.00106	CcSEcCtD
Dactinomycin—Vomiting—Pazopanib—kidney cancer	9.19e-05	0.00106	CcSEcCtD
Dactinomycin—Anaemia—Vincristine—kidney cancer	9.13e-05	0.00105	CcSEcCtD
Dactinomycin—Rash—Pazopanib—kidney cancer	9.11e-05	0.00105	CcSEcCtD
Dactinomycin—Nausea—Temsirolimus—kidney cancer	9.11e-05	0.00105	CcSEcCtD
Dactinomycin—Anorexia—Sunitinib—kidney cancer	9.09e-05	0.00105	CcSEcCtD
Dactinomycin—Abdominal pain—Vinblastine—kidney cancer	9.06e-05	0.00104	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Sorafenib—kidney cancer	9.03e-05	0.00104	CcSEcCtD
Dactinomycin—Body temperature increased—Everolimus—kidney cancer	9.02e-05	0.00104	CcSEcCtD
Dactinomycin—Abdominal pain—Everolimus—kidney cancer	9.02e-05	0.00104	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Erlotinib—kidney cancer	9e-05	0.00104	CcSEcCtD
Dactinomycin—Pharyngitis—Paclitaxel—kidney cancer	8.95e-05	0.00103	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—kidney cancer	8.91e-05	0.00103	CcSEcCtD
Dactinomycin—Leukopenia—Vincristine—kidney cancer	8.84e-05	0.00102	CcSEcCtD
Dactinomycin—Pancytopenia—Capecitabine—kidney cancer	8.78e-05	0.00101	CcSEcCtD
Dactinomycin—Abdominal pain—Erlotinib—kidney cancer	8.7e-05	0.001	CcSEcCtD
Dactinomycin—Body temperature increased—Erlotinib—kidney cancer	8.7e-05	0.001	CcSEcCtD
Dactinomycin—Ill-defined disorder—Gemcitabine—kidney cancer	8.7e-05	0.001	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Sunitinib—kidney cancer	8.68e-05	0.001	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—kidney cancer	8.68e-05	0.001	CcSEcCtD
Dactinomycin—Anaemia—Gemcitabine—kidney cancer	8.66e-05	0.000998	CcSEcCtD
Dactinomycin—Neutropenia—Capecitabine—kidney cancer	8.64e-05	0.000996	CcSEcCtD
Dactinomycin—Decreased appetite—Sorafenib—kidney cancer	8.61e-05	0.000992	CcSEcCtD
Dactinomycin—Nausea—Pazopanib—kidney cancer	8.59e-05	0.000989	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—kidney cancer	8.58e-05	0.000989	CcSEcCtD
Dactinomycin—Fatigue—Sorafenib—kidney cancer	8.54e-05	0.000984	CcSEcCtD
Dactinomycin—Erythema multiforme—Paclitaxel—kidney cancer	8.52e-05	0.000982	CcSEcCtD
Dactinomycin—Pain—Sorafenib—kidney cancer	8.47e-05	0.000976	CcSEcCtD
Dactinomycin—Malaise—Gemcitabine—kidney cancer	8.45e-05	0.000974	CcSEcCtD
Dactinomycin—Hypersensitivity—Vinblastine—kidney cancer	8.44e-05	0.000973	CcSEcCtD
Dactinomycin—Myalgia—Vincristine—kidney cancer	8.41e-05	0.000969	CcSEcCtD
Dactinomycin—Hypersensitivity—Everolimus—kidney cancer	8.41e-05	0.000969	CcSEcCtD
Dactinomycin—Leukopenia—Gemcitabine—kidney cancer	8.39e-05	0.000967	CcSEcCtD
Dactinomycin—Flushing—Paclitaxel—kidney cancer	8.37e-05	0.000964	CcSEcCtD
Dactinomycin—Pneumonia—Capecitabine—kidney cancer	8.29e-05	0.000955	CcSEcCtD
Dactinomycin—Decreased appetite—Sunitinib—kidney cancer	8.29e-05	0.000955	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—kidney cancer	8.24e-05	0.000949	CcSEcCtD
Dactinomycin—Asthenia—Vinblastine—kidney cancer	8.22e-05	0.000947	CcSEcCtD
Dactinomycin—Fatigue—Sunitinib—kidney cancer	8.22e-05	0.000947	CcSEcCtD
Dactinomycin—Asthenia—Everolimus—kidney cancer	8.19e-05	0.000943	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	8.17e-05	0.000941	CcSEcCtD
Dactinomycin—Pain—Sunitinib—kidney cancer	8.15e-05	0.000939	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Sorafenib—kidney cancer	8.1e-05	0.000933	CcSEcCtD
Dactinomycin—Chills—Paclitaxel—kidney cancer	8.09e-05	0.000932	CcSEcCtD
Dactinomycin—Oedema—Vincristine—kidney cancer	8.06e-05	0.000929	CcSEcCtD
Dactinomycin—Stomatitis—Capecitabine—kidney cancer	8.03e-05	0.000925	CcSEcCtD
Dactinomycin—Infection—Vincristine—kidney cancer	8.01e-05	0.000923	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—kidney cancer	8e-05	0.000922	CcSEcCtD
Dactinomycin—Myalgia—Gemcitabine—kidney cancer	7.98e-05	0.000919	CcSEcCtD
Dactinomycin—Alopecia—Paclitaxel—kidney cancer	7.96e-05	0.000918	CcSEcCtD
Dactinomycin—Asthenia—Erlotinib—kidney cancer	7.9e-05	0.00091	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vincristine—kidney cancer	7.89e-05	0.00091	CcSEcCtD
Dactinomycin—Discomfort—Gemcitabine—kidney cancer	7.88e-05	0.000908	CcSEcCtD
Dactinomycin—Erythema—Paclitaxel—kidney cancer	7.85e-05	0.000904	CcSEcCtD
Dactinomycin—Diarrhoea—Vinblastine—kidney cancer	7.84e-05	0.000903	CcSEcCtD
Dactinomycin—Body temperature increased—Sorafenib—kidney cancer	7.83e-05	0.000902	CcSEcCtD
Dactinomycin—Abdominal pain—Sorafenib—kidney cancer	7.83e-05	0.000902	CcSEcCtD
Dactinomycin—Diarrhoea—Everolimus—kidney cancer	7.81e-05	0.0009	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Sunitinib—kidney cancer	7.79e-05	0.000898	CcSEcCtD
Dactinomycin—Agranulocytosis—Capecitabine—kidney cancer	7.69e-05	0.000886	CcSEcCtD
Dactinomycin—Anorexia—Vincristine—kidney cancer	7.69e-05	0.000886	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—kidney cancer	7.67e-05	0.000884	CcSEcCtD
Dactinomycin—Oedema—Gemcitabine—kidney cancer	7.65e-05	0.000881	CcSEcCtD
Dactinomycin—Infection—Gemcitabine—kidney cancer	7.6e-05	0.000876	CcSEcCtD
Dactinomycin—Abdominal pain—Sunitinib—kidney cancer	7.54e-05	0.000868	CcSEcCtD
Dactinomycin—Body temperature increased—Sunitinib—kidney cancer	7.54e-05	0.000868	CcSEcCtD
Dactinomycin—Diarrhoea—Erlotinib—kidney cancer	7.53e-05	0.000868	CcSEcCtD
Dactinomycin—Thrombocytopenia—Gemcitabine—kidney cancer	7.49e-05	0.000863	CcSEcCtD
Dactinomycin—Hepatitis—Capecitabine—kidney cancer	7.4e-05	0.000852	CcSEcCtD
Dactinomycin—ABCC1—ABC-family proteins mediated transport—ABCB1—kidney cancer	7.38e-05	0.011	CbGpPWpGaD
Dactinomycin—Musculoskeletal discomfort—Vincristine—kidney cancer	7.35e-05	0.000846	CcSEcCtD
Dactinomycin—Pharyngitis—Capecitabine—kidney cancer	7.34e-05	0.000846	CcSEcCtD
Dactinomycin—Hypersensitivity—Sorafenib—kidney cancer	7.3e-05	0.000841	CcSEcCtD
Dactinomycin—Anorexia—Gemcitabine—kidney cancer	7.29e-05	0.00084	CcSEcCtD
Dactinomycin—Vomiting—Vinblastine—kidney cancer	7.28e-05	0.000839	CcSEcCtD
Dactinomycin—Ill-defined disorder—Paclitaxel—kidney cancer	7.28e-05	0.000839	CcSEcCtD
Dactinomycin—Vomiting—Everolimus—kidney cancer	7.26e-05	0.000836	CcSEcCtD
Dactinomycin—Anaemia—Paclitaxel—kidney cancer	7.25e-05	0.000836	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ATP7B—kidney cancer	7.23e-05	0.0108	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ANXA2—kidney cancer	7.23e-05	0.0108	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	7.23e-05	0.0108	CbGpPWpGaD
Dactinomycin—Rash—Everolimus—kidney cancer	7.2e-05	0.000829	CcSEcCtD
Dactinomycin—Asthenia—Sorafenib—kidney cancer	7.11e-05	0.000819	CcSEcCtD
Dactinomycin—Malaise—Paclitaxel—kidney cancer	7.08e-05	0.000815	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—kidney cancer	7.03e-05	0.00081	CcSEcCtD
Dactinomycin—Leukopenia—Paclitaxel—kidney cancer	7.02e-05	0.000809	CcSEcCtD
Dactinomycin—Hypersensitivity—Sunitinib—kidney cancer	7.02e-05	0.000809	CcSEcCtD
Dactinomycin—Decreased appetite—Vincristine—kidney cancer	7.01e-05	0.000808	CcSEcCtD
Dactinomycin—Vomiting—Erlotinib—kidney cancer	7e-05	0.000807	CcSEcCtD
Dactinomycin—Erythema multiforme—Capecitabine—kidney cancer	6.99e-05	0.000806	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	6.97e-05	0.000803	CcSEcCtD
Dactinomycin—Fatigue—Vincristine—kidney cancer	6.95e-05	0.000801	CcSEcCtD
Dactinomycin—Rash—Erlotinib—kidney cancer	6.94e-05	0.0008	CcSEcCtD
Dactinomycin—Pain—Vincristine—kidney cancer	6.89e-05	0.000794	CcSEcCtD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	6.88e-05	0.0103	CbGpPWpGaD
Dactinomycin—Flushing—Capecitabine—kidney cancer	6.86e-05	0.000791	CcSEcCtD
Dactinomycin—Asthenia—Sunitinib—kidney cancer	6.84e-05	0.000788	CcSEcCtD
Dactinomycin—Nausea—Vinblastine—kidney cancer	6.8e-05	0.000784	CcSEcCtD
Dactinomycin—Nausea—Everolimus—kidney cancer	6.78e-05	0.000781	CcSEcCtD
Dactinomycin—Diarrhoea—Sorafenib—kidney cancer	6.78e-05	0.000781	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—PTGS2—kidney cancer	6.73e-05	0.0101	CbGpPWpGaD
Dactinomycin—Myalgia—Paclitaxel—kidney cancer	6.68e-05	0.00077	CcSEcCtD
Dactinomycin—Decreased appetite—Gemcitabine—kidney cancer	6.65e-05	0.000766	CcSEcCtD
Dactinomycin—Chills—Capecitabine—kidney cancer	6.64e-05	0.000765	CcSEcCtD
Dactinomycin—Discomfort—Paclitaxel—kidney cancer	6.6e-05	0.00076	CcSEcCtD
Dactinomycin—Fatigue—Gemcitabine—kidney cancer	6.59e-05	0.00076	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vincristine—kidney cancer	6.59e-05	0.00076	CcSEcCtD
Dactinomycin—Pain—Gemcitabine—kidney cancer	6.54e-05	0.000754	CcSEcCtD
Dactinomycin—Nausea—Erlotinib—kidney cancer	6.54e-05	0.000754	CcSEcCtD
Dactinomycin—Alopecia—Capecitabine—kidney cancer	6.54e-05	0.000753	CcSEcCtD
Dactinomycin—Diarrhoea—Sunitinib—kidney cancer	6.52e-05	0.000751	CcSEcCtD
Dactinomycin—Erythema—Capecitabine—kidney cancer	6.44e-05	0.000742	CcSEcCtD
Dactinomycin—Oedema—Paclitaxel—kidney cancer	6.4e-05	0.000738	CcSEcCtD
Dactinomycin—Abdominal pain—Vincristine—kidney cancer	6.37e-05	0.000734	CcSEcCtD
Dactinomycin—Body temperature increased—Vincristine—kidney cancer	6.37e-05	0.000734	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—kidney cancer	6.36e-05	0.000733	CcSEcCtD
Dactinomycin—Infection—Paclitaxel—kidney cancer	6.36e-05	0.000733	CcSEcCtD
Dactinomycin—Feeling abnormal—Gemcitabine—kidney cancer	6.3e-05	0.000726	CcSEcCtD
Dactinomycin—Vomiting—Sorafenib—kidney cancer	6.3e-05	0.000726	CcSEcCtD
Dactinomycin—Thrombocytopenia—Paclitaxel—kidney cancer	6.27e-05	0.000722	CcSEcCtD
Dactinomycin—Rash—Sorafenib—kidney cancer	6.25e-05	0.00072	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.21e-05	0.000715	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.21e-05	0.000715	CcSEcCtD
Dactinomycin—Anorexia—Paclitaxel—kidney cancer	6.1e-05	0.000703	CcSEcCtD
Dactinomycin—Vomiting—Sunitinib—kidney cancer	6.06e-05	0.000698	CcSEcCtD
Dactinomycin—Body temperature increased—Gemcitabine—kidney cancer	6.05e-05	0.000697	CcSEcCtD
Dactinomycin—Rash—Sunitinib—kidney cancer	6.01e-05	0.000693	CcSEcCtD
Dactinomycin—Ill-defined disorder—Capecitabine—kidney cancer	5.97e-05	0.000688	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—kidney cancer	5.96e-05	0.000686	CcSEcCtD
Dactinomycin—Anaemia—Capecitabine—kidney cancer	5.95e-05	0.000686	CcSEcCtD
Dactinomycin—Hypersensitivity—Vincristine—kidney cancer	5.94e-05	0.000684	CcSEcCtD
Dactinomycin—Nausea—Sorafenib—kidney cancer	5.88e-05	0.000678	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.83e-05	0.000672	CcSEcCtD
Dactinomycin—Malaise—Capecitabine—kidney cancer	5.81e-05	0.000669	CcSEcCtD
Dactinomycin—Asthenia—Vincristine—kidney cancer	5.78e-05	0.000667	CcSEcCtD
Dactinomycin—Leukopenia—Capecitabine—kidney cancer	5.76e-05	0.000664	CcSEcCtD
Dactinomycin—Nausea—Sunitinib—kidney cancer	5.66e-05	0.000652	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—kidney cancer	5.66e-05	0.000652	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—kidney cancer	5.57e-05	0.000642	CcSEcCtD
Dactinomycin—Decreased appetite—Paclitaxel—kidney cancer	5.57e-05	0.000641	CcSEcCtD
Dactinomycin—Fatigue—Paclitaxel—kidney cancer	5.52e-05	0.000636	CcSEcCtD
Dactinomycin—Diarrhoea—Vincristine—kidney cancer	5.52e-05	0.000636	CcSEcCtD
Dactinomycin—Asthenia—Gemcitabine—kidney cancer	5.49e-05	0.000632	CcSEcCtD
Dactinomycin—Myalgia—Capecitabine—kidney cancer	5.48e-05	0.000632	CcSEcCtD
Dactinomycin—Pain—Paclitaxel—kidney cancer	5.48e-05	0.000631	CcSEcCtD
Dactinomycin—Discomfort—Capecitabine—kidney cancer	5.42e-05	0.000624	CcSEcCtD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	5.37e-05	0.00803	CbGpPWpGaD
Dactinomycin—Pneumonia—Doxorubicin—kidney cancer	5.34e-05	0.000616	CcSEcCtD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—KDR—kidney cancer	5.32e-05	0.00794	CbGpPWpGaD
Dactinomycin—ABCC1—S1P1 pathway—VEGFA—kidney cancer	5.3e-05	0.00792	CbGpPWpGaD
Dactinomycin—Feeling abnormal—Paclitaxel—kidney cancer	5.28e-05	0.000608	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.27e-05	0.000607	CcSEcCtD
Dactinomycin—Oedema—Capecitabine—kidney cancer	5.26e-05	0.000606	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Paclitaxel—kidney cancer	5.24e-05	0.000603	CcSEcCtD
Dactinomycin—Diarrhoea—Gemcitabine—kidney cancer	5.23e-05	0.000603	CcSEcCtD
Dactinomycin—Infection—Capecitabine—kidney cancer	5.22e-05	0.000602	CcSEcCtD
Dactinomycin—ABCC1—Arachidonic acid metabolism—CYP1A1—kidney cancer	5.22e-05	0.0078	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	5.22e-05	0.0078	CbGpPWpGaD
Dactinomycin—Stomatitis—Doxorubicin—kidney cancer	5.18e-05	0.000597	CcSEcCtD
Dactinomycin—Thrombocytopenia—Capecitabine—kidney cancer	5.15e-05	0.000593	CcSEcCtD
Dactinomycin—Vomiting—Vincristine—kidney cancer	5.13e-05	0.000591	CcSEcCtD
Dactinomycin—ABCB1—Allograft Rejection—LRRK2—kidney cancer	5.09e-05	0.0076	CbGpPWpGaD
Dactinomycin—Rash—Vincristine—kidney cancer	5.08e-05	0.000586	CcSEcCtD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—kidney cancer	5.07e-05	0.00758	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	5.06e-05	0.00756	CbGpPWpGaD
Dactinomycin—Body temperature increased—Paclitaxel—kidney cancer	5.06e-05	0.000583	CcSEcCtD
Dactinomycin—Abdominal pain—Paclitaxel—kidney cancer	5.06e-05	0.000583	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—MAPK3—kidney cancer	5.02e-05	0.00749	CbGpPWpGaD
Dactinomycin—Anorexia—Capecitabine—kidney cancer	5.01e-05	0.000577	CcSEcCtD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	5e-05	0.00746	CbGpPWpGaD
Dactinomycin—Agranulocytosis—Doxorubicin—kidney cancer	4.96e-05	0.000571	CcSEcCtD
Dactinomycin—Vomiting—Gemcitabine—kidney cancer	4.86e-05	0.00056	CcSEcCtD
Dactinomycin—Rash—Gemcitabine—kidney cancer	4.82e-05	0.000556	CcSEcCtD
Dactinomycin—Nausea—Vincristine—kidney cancer	4.79e-05	0.000552	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.79e-05	0.000552	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—MAPK1—kidney cancer	4.77e-05	0.00713	CbGpPWpGaD
Dactinomycin—Hepatitis—Doxorubicin—kidney cancer	4.77e-05	0.000549	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—kidney cancer	4.73e-05	0.000545	CcSEcCtD
Dactinomycin—Hypersensitivity—Paclitaxel—kidney cancer	4.72e-05	0.000544	CcSEcCtD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—RYR1—kidney cancer	4.62e-05	0.0069	CbGpPWpGaD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	4.61e-05	0.00689	CbGpPWpGaD
Dactinomycin—Asthenia—Paclitaxel—kidney cancer	4.59e-05	0.000529	CcSEcCtD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	4.57e-05	0.00683	CbGpPWpGaD
Dactinomycin—Decreased appetite—Capecitabine—kidney cancer	4.57e-05	0.000526	CcSEcCtD
Dactinomycin—Nausea—Gemcitabine—kidney cancer	4.54e-05	0.000523	CcSEcCtD
Dactinomycin—Fatigue—Capecitabine—kidney cancer	4.53e-05	0.000522	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—kidney cancer	4.51e-05	0.000519	CcSEcCtD
Dactinomycin—Pain—Capecitabine—kidney cancer	4.49e-05	0.000518	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—kidney cancer	4.43e-05	0.00051	CcSEcCtD
Dactinomycin—Diarrhoea—Paclitaxel—kidney cancer	4.38e-05	0.000505	CcSEcCtD
Dactinomycin—Feeling abnormal—Capecitabine—kidney cancer	4.33e-05	0.000499	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Capecitabine—kidney cancer	4.3e-05	0.000495	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—kidney cancer	4.28e-05	0.000493	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—kidney cancer	4.21e-05	0.000485	CcSEcCtD
Dactinomycin—Abdominal pain—Capecitabine—kidney cancer	4.15e-05	0.000479	CcSEcCtD
Dactinomycin—Body temperature increased—Capecitabine—kidney cancer	4.15e-05	0.000479	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—kidney cancer	4.15e-05	0.000478	CcSEcCtD
Dactinomycin—Vomiting—Paclitaxel—kidney cancer	4.07e-05	0.000469	CcSEcCtD
Dactinomycin—Rash—Paclitaxel—kidney cancer	4.04e-05	0.000465	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—kidney cancer	4e-05	0.00597	CbGpPWpGaD
Dactinomycin—Hypersensitivity—Capecitabine—kidney cancer	3.87e-05	0.000446	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—kidney cancer	3.85e-05	0.000444	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—kidney cancer	3.84e-05	0.000442	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.81e-05	0.00569	CbGpPWpGaD
Dactinomycin—Nausea—Paclitaxel—kidney cancer	3.8e-05	0.000438	CcSEcCtD
Dactinomycin—Asthenia—Capecitabine—kidney cancer	3.77e-05	0.000434	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—kidney cancer	3.74e-05	0.000431	CcSEcCtD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	3.72e-05	0.00556	CbGpPWpGaD
Dactinomycin—Leukopenia—Doxorubicin—kidney cancer	3.72e-05	0.000428	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.68e-05	0.0055	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	3.66e-05	0.00546	CbGpPWpGaD
Dactinomycin—Diarrhoea—Capecitabine—kidney cancer	3.6e-05	0.000414	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—kidney cancer	3.53e-05	0.000407	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—kidney cancer	3.49e-05	0.000402	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—kidney cancer	3.39e-05	0.00039	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—kidney cancer	3.37e-05	0.000388	CcSEcCtD
Dactinomycin—Vomiting—Capecitabine—kidney cancer	3.34e-05	0.000385	CcSEcCtD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—RYR1—kidney cancer	3.34e-05	0.00499	CbGpPWpGaD
Dactinomycin—Thrombocytopenia—Doxorubicin—kidney cancer	3.32e-05	0.000382	CcSEcCtD
Dactinomycin—Rash—Capecitabine—kidney cancer	3.31e-05	0.000382	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	3.27e-05	0.00489	CbGpPWpGaD
Dactinomycin—Anorexia—Doxorubicin—kidney cancer	3.23e-05	0.000372	CcSEcCtD
Dactinomycin—Nausea—Capecitabine—kidney cancer	3.12e-05	0.00036	CcSEcCtD
Dactinomycin—ABCC1—Arachidonic acid metabolism—PTGS2—kidney cancer	3.1e-05	0.00464	CbGpPWpGaD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.09e-05	0.000356	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—kidney cancer	2.94e-05	0.000339	CcSEcCtD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—RYR1—kidney cancer	2.94e-05	0.00439	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—kidney cancer	2.93e-05	0.00438	CbGpPWpGaD
Dactinomycin—Fatigue—Doxorubicin—kidney cancer	2.92e-05	0.000337	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.91e-05	0.00434	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL13—kidney cancer	2.9e-05	0.00434	CbGpPWpGaD
Dactinomycin—Pain—Doxorubicin—kidney cancer	2.9e-05	0.000334	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—kidney cancer	2.79e-05	0.000322	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—kidney cancer	2.77e-05	0.000319	CcSEcCtD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	2.75e-05	0.00411	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	2.74e-05	0.00409	CbGpPWpGaD
Dactinomycin—Body temperature increased—Doxorubicin—kidney cancer	2.68e-05	0.000309	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—kidney cancer	2.68e-05	0.000309	CcSEcCtD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.66e-05	0.00397	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	2.66e-05	0.00397	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.65e-05	0.00396	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.65e-05	0.00396	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.65e-05	0.00396	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	2.63e-05	0.00393	CbGpPWpGaD
Dactinomycin—Hypersensitivity—Doxorubicin—kidney cancer	2.5e-05	0.000288	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—kidney cancer	2.43e-05	0.00028	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—kidney cancer	2.32e-05	0.000267	CcSEcCtD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TP53—kidney cancer	2.27e-05	0.00339	CbGpPWpGaD
Dactinomycin—Vomiting—Doxorubicin—kidney cancer	2.15e-05	0.000248	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—kidney cancer	2.14e-05	0.000246	CcSEcCtD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	2.01e-05	0.00301	CbGpPWpGaD
Dactinomycin—Nausea—Doxorubicin—kidney cancer	2.01e-05	0.000232	CcSEcCtD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	1.99e-05	0.00298	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	1.98e-05	0.00295	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.97e-05	0.00295	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.92e-05	0.00286	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.92e-05	0.00286	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.92e-05	0.00286	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	1.77e-05	0.00264	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.72e-05	0.00257	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ACY1—kidney cancer	1.71e-05	0.00255	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	1.71e-05	0.00255	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	1.71e-05	0.00255	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.69e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.69e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.69e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.64e-05	0.00246	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CCBL1—kidney cancer	1.63e-05	0.00244	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	1.62e-05	0.00242	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	1.59e-05	0.00237	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ACY1—kidney cancer	1.5e-05	0.00225	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AMER1—kidney cancer	1.48e-05	0.0022	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.46e-05	0.00218	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PDHB—kidney cancer	1.45e-05	0.00217	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	1.42e-05	0.00212	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	1.41e-05	0.0021	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.4e-05	0.00209	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CCBL1—kidney cancer	1.37e-05	0.00204	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.35e-05	0.00202	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	1.29e-05	0.00193	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PDHB—kidney cancer	1.28e-05	0.00191	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GPC3—kidney cancer	1.24e-05	0.00185	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.24e-05	0.00185	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CCBL1—kidney cancer	1.2e-05	0.0018	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GLIPR1—kidney cancer	1.18e-05	0.00177	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PPAT—kidney cancer	1.18e-05	0.00177	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.17e-05	0.00175	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	1.16e-05	0.00173	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.16e-05	0.00173	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.16e-05	0.00173	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ST3GAL2—kidney cancer	1.14e-05	0.00171	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—APRT—kidney cancer	1.1e-05	0.00165	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—FH—kidney cancer	1.1e-05	0.00165	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.09e-05	0.00163	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.09e-05	0.00162	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.08e-05	0.00161	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PGK1—kidney cancer	1.07e-05	0.0016	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SLC5A3—kidney cancer	1.07e-05	0.0016	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.07e-05	0.00159	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.07e-05	0.00159	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—LDHB—kidney cancer	1.05e-05	0.00157	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SFRP2—kidney cancer	1.05e-05	0.00157	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PPAT—kidney cancer	1.04e-05	0.00156	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GLIPR1—kidney cancer	1.04e-05	0.00156	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GPC3—kidney cancer	1.04e-05	0.00155	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.01e-05	0.00151	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CA2—kidney cancer	1.01e-05	0.0015	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALAD—kidney cancer	9.82e-06	0.00147	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TCEB1—kidney cancer	9.8e-06	0.00146	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TCEB2—kidney cancer	9.8e-06	0.00146	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.76e-06	0.00146	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—FH—kidney cancer	9.69e-06	0.00145	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—APRT—kidney cancer	9.69e-06	0.00145	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ST3GAL2—kidney cancer	9.58e-06	0.00143	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	9.54e-06	0.00142	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL2—kidney cancer	9.49e-06	0.00142	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	9.45e-06	0.00141	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALDH1A1—kidney cancer	9.36e-06	0.0014	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	9.32e-06	0.00139	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.12e-06	0.00136	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.12e-06	0.00136	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.12e-06	0.00136	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GPC3—kidney cancer	9.11e-06	0.00136	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC5A3—kidney cancer	8.98e-06	0.00134	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PGK1—kidney cancer	8.98e-06	0.00134	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.9e-06	0.00133	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CA2—kidney cancer	8.86e-06	0.00132	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—LDHB—kidney cancer	8.8e-06	0.00132	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALAD—kidney cancer	8.64e-06	0.00129	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.59e-06	0.00128	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ST3GAL2—kidney cancer	8.43e-06	0.00126	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALDH1A1—kidney cancer	8.24e-06	0.00123	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ACY1—kidney cancer	8.13e-06	0.00121	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—VEGFA—kidney cancer	8.07e-06	0.00121	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RPL14—kidney cancer	7.97e-06	0.00119	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PGK1—kidney cancer	7.9e-06	0.00118	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC5A3—kidney cancer	7.9e-06	0.00118	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—LDHB—kidney cancer	7.75e-06	0.00116	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.71e-06	0.00115	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CA9—kidney cancer	7.63e-06	0.00114	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.46e-06	0.00111	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ITPR2—kidney cancer	7.21e-06	0.00108	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PDHB—kidney cancer	6.91e-06	0.00103	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.78e-06	0.00101	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CA9—kidney cancer	6.72e-06	0.001	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.66e-06	0.000995	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CCBL1—kidney cancer	6.5e-06	0.000971	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CRABP1—kidney cancer	6.49e-06	0.00097	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PSMD7—kidney cancer	6.04e-06	0.000902	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	6.04e-06	0.000902	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ITPR2—kidney cancer	6.03e-06	0.000901	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CRABP1—kidney cancer	5.71e-06	0.000853	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GLIPR1—kidney cancer	5.64e-06	0.000842	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PPAT—kidney cancer	5.64e-06	0.000842	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.56e-06	0.000831	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ACHE—kidney cancer	5.5e-06	0.000822	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTT1—kidney cancer	5.5e-06	0.000822	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SLC2A1—kidney cancer	5.46e-06	0.000816	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—JUNB—kidney cancer	5.42e-06	0.00081	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ITPR2—kidney cancer	5.31e-06	0.000793	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—FH—kidney cancer	5.24e-06	0.000783	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—APRT—kidney cancer	5.24e-06	0.000783	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5.23e-06	0.000781	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SCARB1—kidney cancer	5.21e-06	0.000778	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	5.17e-06	0.000772	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS1—kidney cancer	5.16e-06	0.00077	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PSMD7—kidney cancer	5.06e-06	0.000755	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	5.06e-06	0.000755	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GPC3—kidney cancer	4.93e-06	0.000736	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTT1—kidney cancer	4.84e-06	0.000723	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ACHE—kidney cancer	4.84e-06	0.000723	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.81e-06	0.000719	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—BCHE—kidney cancer	4.79e-06	0.000716	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CA2—kidney cancer	4.79e-06	0.000716	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.79e-06	0.000715	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC5A5—kidney cancer	4.74e-06	0.000707	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALAD—kidney cancer	4.67e-06	0.000698	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.65e-06	0.000694	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SCARB1—kidney cancer	4.58e-06	0.000685	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC2A1—kidney cancer	4.57e-06	0.000683	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.57e-06	0.000682	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ST3GAL2—kidney cancer	4.56e-06	0.000681	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.56e-06	0.000681	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS1—kidney cancer	4.54e-06	0.000678	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.52e-06	0.000676	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALDH1A1—kidney cancer	4.46e-06	0.000666	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PSMD7—kidney cancer	4.45e-06	0.000665	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.44e-06	0.000663	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN2B—kidney cancer	4.41e-06	0.000659	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.41e-06	0.000659	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.36e-06	0.000652	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PGK1—kidney cancer	4.27e-06	0.000638	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC5A3—kidney cancer	4.27e-06	0.000638	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—BCHE—kidney cancer	4.22e-06	0.00063	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—LDHB—kidney cancer	4.19e-06	0.000626	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC5A5—kidney cancer	4.17e-06	0.000622	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC2A1—kidney cancer	4.02e-06	0.000601	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.98e-06	0.000595	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.87e-06	0.000578	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.84e-06	0.000573	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTP1—kidney cancer	3.81e-06	0.00057	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.77e-06	0.000563	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.66e-06	0.000547	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CA9—kidney cancer	3.63e-06	0.000543	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ABCB1—kidney cancer	3.61e-06	0.000539	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.58e-06	0.000535	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HIF1A—kidney cancer	3.53e-06	0.000527	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TSC2—kidney cancer	3.52e-06	0.000526	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTM1—kidney cancer	3.51e-06	0.000524	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.39e-06	0.000506	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTP1—kidney cancer	3.36e-06	0.000501	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP1A1—kidney cancer	3.32e-06	0.000496	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ABCB1—kidney cancer	3.18e-06	0.000475	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.11e-06	0.000465	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—APC—kidney cancer	3.11e-06	0.000464	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KIT—kidney cancer	3.11e-06	0.000464	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CRABP1—kidney cancer	3.09e-06	0.000461	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTM1—kidney cancer	3.08e-06	0.000461	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.01e-06	0.000449	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP1A1—kidney cancer	2.92e-06	0.000437	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—BRAF—kidney cancer	2.92e-06	0.000436	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ITPR2—kidney cancer	2.87e-06	0.000429	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.73e-06	0.000408	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ACHE—kidney cancer	2.62e-06	0.000391	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTT1—kidney cancer	2.62e-06	0.000391	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SCARB1—kidney cancer	2.48e-06	0.00037	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—POMC—kidney cancer	2.48e-06	0.00037	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS1—kidney cancer	2.45e-06	0.000366	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RAF1—kidney cancer	2.44e-06	0.000364	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERBB2—kidney cancer	2.41e-06	0.00036	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PSMD7—kidney cancer	2.41e-06	0.000359	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MTOR—kidney cancer	2.38e-06	0.000356	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CD4—kidney cancer	2.38e-06	0.000355	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTGS2—kidney cancer	2.36e-06	0.000352	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—BCHE—kidney cancer	2.28e-06	0.000341	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC5A5—kidney cancer	2.25e-06	0.000337	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1B—kidney cancer	2.23e-06	0.000334	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—POMC—kidney cancer	2.18e-06	0.000326	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC2A1—kidney cancer	2.18e-06	0.000325	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CTNNB1—kidney cancer	2.11e-06	0.000315	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.07e-06	0.00031	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTEN—kidney cancer	2.06e-06	0.000307	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS2—kidney cancer	1.98e-06	0.000295	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTP1—kidney cancer	1.81e-06	0.000271	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MAPK3—kidney cancer	1.76e-06	0.000263	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS2—kidney cancer	1.74e-06	0.00026	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTEN—kidney cancer	1.72e-06	0.000257	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MYC—kidney cancer	1.71e-06	0.000255	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MAPK1—kidney cancer	1.67e-06	0.00025	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTM1—kidney cancer	1.67e-06	0.000249	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP1A1—kidney cancer	1.58e-06	0.000236	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KRAS—kidney cancer	1.58e-06	0.000236	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTEN—kidney cancer	1.52e-06	0.000227	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CA—kidney cancer	1.45e-06	0.000217	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CA—kidney cancer	1.22e-06	0.000182	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—POMC—kidney cancer	1.18e-06	0.000176	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CA—kidney cancer	1.07e-06	0.00016	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS2—kidney cancer	9.4e-07	0.00014	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTEN—kidney cancer	8.2e-07	0.000122	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CA—kidney cancer	5.78e-07	8.64e-05	CbGpPWpGaD
